Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-881

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 51655-881). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (51655 881 30 Rev A 07 22)

Label (51655 881 30 Rev A 07 22)
Label for Atorvastatin Calcium Tablets, USP 80 mg, containing 30 film-coated tablets. The label indicates prescription use only and storage instructions. It is repackaged by Northwind Pharmaceuticals, Indianapolis, IN, and includes NDC 51655-881-30 with batch and expiration details.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A cumulative incidence line graph comparing Atorvastatin to Placebo over a period of 3.5 years. The Y-axis shows cumulative incidence percentage from 0 to 4%, while the X-axis represents time in years. The graph includes hazard ratio and p-value statistics at the bottom.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A cumulative hazard curve comparing Atorvastatin with Placebo over a four-year follow-up period. The x-axis represents time in years to the first primary endpoint, and the y-axis shows the cumulative hazard percentage. The Atorvastatin group shows a consistently lower hazard than the Placebo group throughout the study duration.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over five years between Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects. The graph includes a hazard ratio (HR) of 0.78 with confidence intervals and a p-value indicating statistical significance.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium as shown in the image, depicting the molecular arrangement including two calcium ions as part of its composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.